Pharmaceutical Product Supply – Adenovirus Vaccine (Live, Oral)

The contract entails the supply and delivery of 9,000 packages of Adenovirus Type 4 and Type 7 Vaccine, Live, Oral, identified by NSN 6505016420106 and NDC 51285-0138-50, to support military health readiness. The vaccine must be shipped FOB destination to two specified locations: Fort Detrick, MD, and San Diego, CA, ensuring timely and secure delivery to designated military health facilities. Each shipment requires full traceability with documented proof of delivery to maintain accountability and compliance with federal pharmaceutical distribution standards. The product falls under NAICS code 325412, indicating pharmaceutical preparation manufacturing, and is managed under a subcontract by the Defense Logistics Agency on behalf of the Department of Defense. The contract was posted on July 14, 2026, and is part of a broader effort to ensure vaccination readiness across U.S. military installations.